2020 Bioelectronic Medicine Forum

Millennium Broadway, New York, NY, April 7, 2020

Tentative Agenda

8:00-8:30

Registration and Coffee

8:30-8:45

Overview of the Bioelectronic Medicine Industry

James Cavuoto, Editor and Publisher, Neurotech Reports
Neurotech Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including key players, technological roots, and market projections.
8:45-9:15

Keynote Address

This keynote session features observations from a major investor and innovator in the medical device industry.
9:15-10:00

Investment in Bioelectronic Medicine

Margot Puerta, Contributing Editor, Neurotech Reports, Moderator
In this session, investment professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine.
10:00-10:15

Refreshment Break

10:15-11:15

Entrepreneur Panel I

James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator
Presentations from executives of emerging bioelectronic medicine firms.
11:15-12:00

New Treatment Modalities

Jennifer French, Senior Editor, Neurotech Reports, Moderator
Marom Bikson, Ph.D., Director, Neural Engineering Laboratory, CCNY
Bioelectronic medicine vendors and researchers now have access to a range of new treatment modalities beyond electrical stimulation, including ultrasound, pulsed RF. and infrared neuromodulation. In this session, we'll discuss the advantages and disadvantages of each.
12:00-1:15

Luncheon

1:15-2:00

Regulatory and Reimbursement Issues

Jeremy Koff, Senior Contributing Editor, Neurotech Reports, Moderator
Startup and established bioelectronic medicine firms face a variety of regulatory and reimbursement issues on the way to commercialization. In this session, we'll explore key considerations in designing clinical trials, obtaining FDA approval, and getting reimbursement from payors.
2:00-3:00

Entrepreneur Panel II

James Cavuoto, Editor, Neurotech Reports, Moderator
Presentations from executives of emerging bioelectronic medicine firms.
3:00-3:15

Refreshment Break

3:15-4:15

Moving from Lab to Bedside

Jennifer French, Senior Editor, Neurotech Reports, Moderator
Presentations from representatives of research institutions and nonprofit organizations seeking to commercialize new bioelectronic medicine therapies.
4:15-5:00

New Applications of Bioelectronic Medicine

James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator
In this closing session, we'll look at new applications for bioelectronic medicine, including potential therapies for treating immunological, dematalogical, and hematalogical disorders.
5:00-7:00

Cocktail Reception

 
 
      

©2020 Neurotech Reports. All rights reserved.